Skip to main content
Top
Published in: Familial Cancer 1/2011

01-03-2011

Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype

Authors: Sung-Hee Han, Jae-Song Ryu, Young-Jin Kim, Han-Ik Cho, Young-Ho Yang, Kyoung-Ryul Lee

Published in: Familial Cancer | Issue 1/2011

Login to get access

Abstract

Germline mutations within the adenomatous polyposis coli (APC) gene are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date more than 900 different APC germline mutations have been characterized worldwide demonstrating allelic heterogeneity. Here, we analyzed the APC gene in 23 DNA samples from unrelated Korean patients with the typical clinical symptoms of FAP by denaturing high-performance liquid chromatography (DHPLC) and direct sequencing. We identified 20 different APC sequence variants, including 9 truncating mutations, 1 missense mutation, 7 polymorphisms, and 3 intronic variants. Nine different truncating mutations, including four novel mutations (p.Leu180TyrfsX5, p.Gly567X, p.Ser1275PhefsX13, p.Leu1280CysfsX8), were detected. The most common mutation was a 5 bp deletion at codon 1,309 (p.Glu1309AspfsX4) as in Western studies. The next most common mutation was p.Ser1275PhefsX13 with a severe form of FAP with many extracolonic manifestations; this was a novel mutation identified in our study and may represent the second hot-spot mutation in a Korean population. Novel mutations are of particular interest because of the unusual phenotypic features shown by patients. In present study, we found new positions associated with thyroid cancer (codon 180) and desmoid tumor (codon 1,280), which have not been previously reported. The results of this molecular study have revealed the existence of novel pathogenic mutations in Korean patients with FAP. In addition to allowing phenotype–genotype correlations to be performed, these results are currently being used in genetic counseling and in patient care.
Literature
1.
go back to reference Bisgaard ML, Fenger K, Bülow S et al (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3:121–125CrossRefPubMed Bisgaard ML, Fenger K, Bülow S et al (1994) Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3:121–125CrossRefPubMed
2.
go back to reference Nieuwenhuis MH, Vasen HF (2007) Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 61:153–161CrossRefPubMed Nieuwenhuis MH, Vasen HF (2007) Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 61:153–161CrossRefPubMed
3.
go back to reference Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600CrossRefPubMed Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600CrossRefPubMed
4.
go back to reference Kinzler KW, Nilbert MC, Su LK et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665CrossRefPubMed Kinzler KW, Nilbert MC, Su LK et al (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665CrossRefPubMed
5.
go back to reference Nagase H, Nakamura Y (1993) Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 2:425–434CrossRefPubMed Nagase H, Nakamura Y (1993) Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 2:425–434CrossRefPubMed
6.
go back to reference Béroud C, Soussi T (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24:121–124CrossRefPubMed Béroud C, Soussi T (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24:121–124CrossRefPubMed
7.
go back to reference Varesco L, Gismondi V, James R et al (1993) APC gene mutations in Italian familial polyposis coli patients. Cancer Detect Prev 17:279–281PubMed Varesco L, Gismondi V, James R et al (1993) APC gene mutations in Italian familial polyposis coli patients. Cancer Detect Prev 17:279–281PubMed
8.
go back to reference Schnitzler M, Koorey D, Dwight T et al (1998) Frequency of codon 1061 and codon 1309 APC mutations in Australian familial adenomatous polyposis patients. Hum Mutat Suppl 1:S56–S57 Schnitzler M, Koorey D, Dwight T et al (1998) Frequency of codon 1061 and codon 1309 APC mutations in Australian familial adenomatous polyposis patients. Hum Mutat Suppl 1:S56–S57
9.
go back to reference Ruiz-Ponte C, Vega A, Carracedo A et al (2001) Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum Mutat 18:355CrossRefPubMed Ruiz-Ponte C, Vega A, Carracedo A et al (2001) Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum Mutat 18:355CrossRefPubMed
10.
go back to reference Gavert N, Yaron Y, Naiman T et al (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat 19:664CrossRefPubMed Gavert N, Yaron Y, Naiman T et al (2002) Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations. Hum Mutat 19:664CrossRefPubMed
11.
go back to reference Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521CrossRefPubMed Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521CrossRefPubMed
12.
go back to reference Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMed Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMed
13.
go back to reference den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124CrossRef den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121–124CrossRef
14.
go back to reference Ogino S, Gulley ML, den Dunnen JT et al (2007) Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6CrossRefPubMed Ogino S, Gulley ML, den Dunnen JT et al (2007) Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6CrossRefPubMed
15.
go back to reference Kim DW, Kim IJ, Kang HC et al (2005) Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 26:281–292CrossRefPubMed Kim DW, Kim IJ, Kang HC et al (2005) Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 26:281–292CrossRefPubMed
16.
go back to reference Armstrong JG, Davies DR, Guy SP et al (1997) APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat 10:376–380CrossRefPubMed Armstrong JG, Davies DR, Guy SP et al (1997) APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat 10:376–380CrossRefPubMed
17.
go back to reference Giarola M, Stagi L, Presciuttini S et al (1993) Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 13:116–123CrossRef Giarola M, Stagi L, Presciuttini S et al (1993) Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 13:116–123CrossRef
18.
go back to reference Hutter P, Rey-Berthod C, Chappuis PO et al (2001) Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Hum Mutat 18:550CrossRefPubMed Hutter P, Rey-Berthod C, Chappuis PO et al (2001) Molecular and clinical characteristics in 32 families affected with familial adenomatous polyposis. Hum Mutat 18:550CrossRefPubMed
19.
go back to reference van der Luijt RB, Khan PM, Vasen HF et al (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat 9:7–16CrossRefPubMed van der Luijt RB, Khan PM, Vasen HF et al (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat 9:7–16CrossRefPubMed
20.
go back to reference Sieber OM, Lamlum H, Crabtree MD et al (2002) Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas. Proc Natl Acad Sci USA 99:2954–2958CrossRefPubMed Sieber OM, Lamlum H, Crabtree MD et al (2002) Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas. Proc Natl Acad Sci USA 99:2954–2958CrossRefPubMed
21.
go back to reference Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159CrossRefPubMed Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159CrossRefPubMed
22.
go back to reference Aretz S, Stienen D, Uhlhaas S et al (2005) Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 42:185–192CrossRefPubMed Aretz S, Stienen D, Uhlhaas S et al (2005) Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 42:185–192CrossRefPubMed
23.
go back to reference Michils G, Tejpar S, Thoelen R et al (2005) Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 25:125–134CrossRefPubMed Michils G, Tejpar S, Thoelen R et al (2005) Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 25:125–134CrossRefPubMed
24.
go back to reference Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ- line mutations in MYH. N Engl J Med 348:791–799CrossRefPubMed Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ- line mutations in MYH. N Engl J Med 348:791–799CrossRefPubMed
25.
go back to reference Aretz S, Uhlhaas S, Goergens H et al (2006) MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119:807–814CrossRefPubMed Aretz S, Uhlhaas S, Goergens H et al (2006) MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119:807–814CrossRefPubMed
27.
go back to reference Won YJ, Park KJ, Kwon HJ et al (1999) Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 44:103–108CrossRefPubMed Won YJ, Park KJ, Kwon HJ et al (1999) Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 44:103–108CrossRefPubMed
28.
go back to reference Cao X, Eu KW, Seow-Choen F et al (2000) APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8:42–48CrossRefPubMed Cao X, Eu KW, Seow-Choen F et al (2000) APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8:42–48CrossRefPubMed
29.
go back to reference Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMed Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMed
30.
go back to reference Bertario L, Russo A, Sala P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed Bertario L, Russo A, Sala P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed
31.
go back to reference Cao X, Hong Y, Eu KW et al (2006) Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression. Am J Gastroenterol 101:2810–2817CrossRefPubMed Cao X, Hong Y, Eu KW et al (2006) Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression. Am J Gastroenterol 101:2810–2817CrossRefPubMed
32.
go back to reference Offerhaus GJ, Entius MM, Giardiello FM (1999) Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 46:667–669PubMed Offerhaus GJ, Entius MM, Giardiello FM (1999) Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 46:667–669PubMed
33.
go back to reference Kadmon M, Tandara A, Herfarth C (2001) Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg polyposis register. Int J Colorectal Dis 16:63–75CrossRefPubMed Kadmon M, Tandara A, Herfarth C (2001) Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg polyposis register. Int J Colorectal Dis 16:63–75CrossRefPubMed
34.
go back to reference Dobbie Z, Spycher M, Mary JL et al (1996) Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet 33:274–280CrossRefPubMed Dobbie Z, Spycher M, Mary JL et al (1996) Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet 33:274–280CrossRefPubMed
35.
go back to reference Wallis YL, Morton DG, McKeown CM et al (1999) Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet 36:14–20PubMed Wallis YL, Morton DG, McKeown CM et al (1999) Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet 36:14–20PubMed
36.
go back to reference Ficari F, Cama A, Valanzano R et al (2000) APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 82:348–353CrossRefPubMed Ficari F, Cama A, Valanzano R et al (2000) APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 82:348–353CrossRefPubMed
37.
go back to reference Aretz S, Stienen D, Friedrichs N et al (2007) Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 28:985–992CrossRefPubMed Aretz S, Stienen D, Friedrichs N et al (2007) Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat 28:985–992CrossRefPubMed
38.
go back to reference Cetta F, Montalto G, Gori M et al (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292CrossRefPubMed Cetta F, Montalto G, Gori M et al (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292CrossRefPubMed
39.
go back to reference Truta B, Allen BA, Conrad PG et al (2003) Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer 2:95–99CrossRefPubMed Truta B, Allen BA, Conrad PG et al (2003) Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer 2:95–99CrossRefPubMed
40.
go back to reference Aretz S, Uhlhaas S, Caspari R et al (2004) Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMed Aretz S, Uhlhaas S, Caspari R et al (2004) Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMed
41.
go back to reference Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumours in familial adenomatous polyposis. Gut 35:377–381CrossRefPubMed Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumours in familial adenomatous polyposis. Gut 35:377–381CrossRefPubMed
42.
43.
go back to reference Caspari R, Olschwang S, Friedl W et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337–340CrossRefPubMed Caspari R, Olschwang S, Friedl W et al (1995) Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337–340CrossRefPubMed
44.
go back to reference Slattery ML, Samowitz W, Ballard L et al (2001) A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res 61:3222 Slattery ML, Samowitz W, Ballard L et al (2001) A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. Cancer Res 61:3222
45.
go back to reference Guerreiro CS, Cravo ML, Brito M et al (2007) The D1822 V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr 85:1592–1597PubMed Guerreiro CS, Cravo ML, Brito M et al (2007) The D1822 V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am J Clin Nutr 85:1592–1597PubMed
46.
go back to reference Ripa R, Bisgaard ML, Bülow S et al (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10:631–637CrossRefPubMed Ripa R, Bisgaard ML, Bülow S et al (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10:631–637CrossRefPubMed
47.
go back to reference Hes FJ, Nielsen M, Bik EC et al (2007) Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 57:71–76CrossRefPubMed Hes FJ, Nielsen M, Bik EC et al (2007) Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut 57:71–76CrossRefPubMed
Metadata
Title
Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype
Authors
Sung-Hee Han
Jae-Song Ryu
Young-Jin Kim
Han-Ik Cho
Young-Ho Yang
Kyoung-Ryul Lee
Publication date
01-03-2011
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2011
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9363-4

Other articles of this Issue 1/2011

Familial Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine